OrthoPediatrics Q3 EPS $(0.13) Beats $(0.22) Estimate, Sales $39.97M Miss $40.37M Estimate
Portfolio Pulse from Benzinga Newsdesk
OrthoPediatrics (NASDAQ:KIDS) reported Q3 losses of $(0.13) per share, beating the analyst consensus estimate of $(0.22) by 40.91%. However, the company's quarterly sales of $39.97 million missed the analyst consensus estimate of $40.37 million by 0.99%. This represents a 160% increase in losses and a 14.37% increase in sales compared to the same period last year.
November 06, 2023 | 9:25 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
OrthoPediatrics reported better than expected Q3 losses but missed on sales. This could have a mixed impact on the stock.
OrthoPediatrics reported a smaller than expected loss for Q3, which is positive for the stock. However, the company missed on sales, which could offset some of the positive sentiment. The net impact on the stock is likely to be mixed.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100